AJR Your Link to CME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shiraishi, S.
Right arrow Articles by Yamashita, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shiraishi, S.
Right arrow Articles by Yamashita, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
DOI:10.2214/AJR.04.0898
AJR 2006; 186:1450-1457
© American Roentgen Ray Society


Original Research

Quantitative Analysis and Effect of Attenuation Correction on Lymph Node Staging of Non-Small Cell Lung Cancer on SPECT and CT

Shinya Shiraishi1, Seiji Tomiguchi1, Daisuke Utsunomiya1, Koichi Kawanaka1, Kazuo Awai1, Syoji Morishita1, Tomoko Okuda1, Koichi Yokotsuka2 and Yasuyuki Yamashita1

1 Department of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto-city, Kumamoto 860-8556, Japan.
2 Nuclear Medicine Department, Hitachi Medical Corporation, Tokyo, Japan.

Received June 7, 2004; accepted after revision March 7, 2005.

 
Address correspondence to S. Shiraishi.


Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
OBJECTIVE. The purpose of our study was to assess quantitative indexes and the effect of attenuation correction on the evaluation of lymph node metastasis in the staging of non-small cell lung cancer (NSCLC) using fused thallium-201 SPECT/CT images.

MATERIALS AND METHODS. We evaluated 156 lymph nodes (66 metastatic, 90 nonmetastatic) from 29 patients with NSCLC. Using our combined SPECT/CT system, all patients underwent 201Tl SPECT and CT examinations immediately (early images) and 3 hr after (delayed images) the injection of 201Tl. SPECT images were reconstructed with and without attenuation correction. For the quantitative evaluation of lymph node metastasis, we calculated the early ratio, the delayed ratio, and the washout ratio for SPECT images and the short-axis diameter for CT images. Receiver operating characteristic (ROC) analysis was performed in each index for the differentiation between metastatic and nonmetastatic lymph nodes. Visual analysis was also performed by two experienced radiologists.

RESULTS. The area under the ROC curve (Az) showed that early ratio and delayed ratio were superior to short-axis diameter for the assessment of lymph node metastasis. In addition, early and delayed ratios on attenuation-corrected images were superior to those ratios on images without attenuation correction. However, the Az value for washout ratio was smaller than that for short-axis diameter. Early ratio on attenuation-corrected images was the most useful index (Az = 0.94). The sensitivity, specificity, and accuracy for early ratio on attenuation-corrected images were 78.8%, 94.4%, and 87.8% for the diagnosis of lymph node metastasis and 84.6%, 100%, and 93.1% for clinical staging (N0-N1 vs N2-N3), respectively. Fused images showed significantly higher diagnostic accuracy than CT images on visual analysis.

CONCLUSION. Quantitative assessment using fused SPECT/CT images is useful for the diagnosis of lymph node metastasis in patients with NSCLC.

Keywords: cancer • CT • lung • lymph node • SPECT • staging


Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Lung cancer is a major cause of death in both men and women worldwide [1]. Non-small cell lung cancer (NSCLC) accounts for approximately 80% of bronchogenic malignancies. After a pathology diagnosis is made, correct lung cancer staging is necessary to estimate the prognosis and to choose the best combination of treatments to improve survival. Because surgery remains the most effective therapy for stages I and II NSCLC [2], the preoperative evaluation of regional lymph node metastasis is essential for assessing the resectability of the primary tumor and disease prognosis [3].

Chest CT, the most commonly used noninvasive imaging method for the clinical staging of NSCLC, is of limited value for lymph node staging [4, 5]. PET with 18F-FDG is a remarkable technical advance [6]: Results of a randomized clinical trial showed that preoperative PET of NSCLC patients reduced the number of futile operations by 50% [7]. Accurately fused functional and morphologic data sets can now be generated with dual-technique PET/CT systems [8], and the use of these instruments has resulted in a significant increase in the number of patients with correct nodal staging [9].

The value of some myocardial perfusion imaging tracers such as thallium-201 [10, 11], technetium-99m sestamibi [12, 13], and 99mTc tetrofosmin [14] for mediastinal lymph node detection in patients undergoing SPECT has been recognized. SPECT/CT hybrid systems yield coregistered dual-technique images. Functional anatomic mapping allows more precise interpretation of scintigrams, and fused images can improve the diagnostic accuracy of SPECT in various clinical situations [15]. However, because CT on the SPECT/CT hybrid system is time-consuming and the quality of anatomic images is inferior to that of conventional CT systems, CT is not suitable for the depiction of small lesions such as metastatic lymph nodes.

We installed a combined SPECT/CT system that is composed of a gantry-free gamma camera and an 8-MDCT scanner. To avoid positional differences between the SPECT and CT studies, imaging can be performed on the same platform. Our system makes possible both attenuation correction and image fusion of SPECT and high-performance CT images.

In the staging of NSCLC using 201Tl SPECT, neither quantitative analyses on a per-lymph node basis using indexes such as early ratio, delayed ratio, and washout ratio, nor studies of the effectiveness of attenuation correction have been reported. Using our combined SPECT/CT system, it is possible to target the region of interest (ROI) on small lesions on SPECT images using coregistered CT images. In this study, we assessed the value of these indexes and the effect of attenuation correction on the evaluation of lymph nodes in the staging of NSCLC using fused 201Tl SPECT/CT images.


Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Patients
We enrolled 29 patients with NSCLC who showed tracer accumulation at the primary site on 201Tl SPECT images. They were 17 men and 12 women who ranged in age from 31 to 87 years (mean, 68 years) who underwent 201Tl SPECT and CT for the preoperative staging of NSCLC between November 2002 and August 2004. Clinical data on each patient are summarized in Table 1. All 29 patients presented with clinical and radiographic or CT signs suggestive of lung cancer; the definitive diagnosis of NSCLC was based on specimens obtained by percutaneously guided CT, transbronchial lung biopsy, or surgery. There were 21 adenocarcinomas and four bronchioloalveolar, one large cell, and three squamous cell carcinomas. Distant metastases had been ruled out by CT, MRI, and bone scintigraphy in all patients. All patients had their clinical-pathologic lymph node status assigned after undergoing thoracotomy (n = 4), videotape-assisted thoracoscopic surgery (n = 13), or sequential follow-up with more than three CT examinations for a mean observation period of 17.1 months (range, 13-26 months) (n = 12). Metastatic lymph nodes were present in 13 patients and nonmetastatic lymph nodes in 16.


View this table:
[in this window]
[in a new window]

 
TABLE 1: Clinical Summary of 29 Patients Studied

 

The institutional review board of the Graduate School of Medical and Pharmaceutical Sciences of Kumamoto University approved the study, as did the institutional ethics committee. Prior informed written consent was obtained from all patients after orally reviewing with them the protocol and types of examinations and after answering all questions.

System Design
We used a combined SPECT/CT system that incorporates a commercially available gantry-free SPECT scanner with dual-head detectors (Skylight, ADAC Laboratories) and an 8-MDCT scanner (LightSpeed Ultra, GE Healthcare). The two instruments were juxtaposed so that the CT table holding the patient could be moved directly into the SPECT scanner before CT. Depending on the target site, we also used an auxiliary plate. A supporting pillar compensated for any sagging of the table due to patient weight. As a result, each patient was positioned identically for SPECT and CT.

SPECT
The patients were scanned with their arms elevated. Early SPECT started at 10-15 min and delayed SPECT at 3 hr after the IV administration of 111 MBq of 201Tl. SPECT data acquisition was performed with a vertex general purpose parallel-hole collimator. A 360° SPECT scan encompassing the thorax and upper abdomen was acquired. SPECT images were obtained at a magnification factor of 1 or 1.46 in a 64 x 64 or 128 x 128 matrix. We acquired 64 projections at 6° intervals in the step-and-shoot mode. Between 45 and 60 sec was required for each projection; the full study required 24-32 min.

CT
Two sets of CT images without contrast administration were obtained in this study. First, with the patient resting and breathing freely, helical CT images for attenuation correction of SPECT images were obtained at 120 kV, 20 mA, 20.0-mm table feed per rotation, 4.0-sec gantry rotation time, 2.5-mm collimation, and 5.0-mm reconstruction. CT images were reconstructed using a standard reconstruction algorithm with a 50-cm field of view to cover both the patient and the table.

Second, CT images for the diagnosis of lymph node metastasis were obtained at 120 kV, 180 mA, 17.5-mm table feed per rotation, 0.7-sec gantry rotation time, 2.5-mm collimation, and 5.0-mm reconstruction. For these examinations, the patients held their breath between inspiration and exhalation while in the supine position. CT images were reconstructed using a standard reconstruction algorithm with a 35-40 cm field of view of the target sites.

Image Processing
Reconstructed CT images were processed into DICOM data and then transferred to Pegasys (ADAC Laboratories), a workstation for SPECT processing. The matrix of the transferred CT images was converted to 128 x 128 for attenuation correction and to 256 x 256 for image fusion. The slice thickness was adjusted to approximately 6 mm. For SPECT reconstruction, the maximum-likelihood expectation maximization (ML-EM) algorithm was used with 12 iterations. Butterworth filtering (cutoff, 0.30-50 cycles per pixel; order, 5-6) was applied for prereconstruction filtering.

One lumen of a three-way cock (inner diameter, 4 mm; length, 10 mm) containing an aqueous solution of 201Tl and a contrast medium was used as an external fiducial marker. To obtain precise registration of both images, external fiducial markers were fixed to the common platform for SPECT and CT, and the two scans were obtained sequentially. Image fusion of SPECT and CT images was manually performed by registration of external fiducial markers of the two images on a workstation [16]. The usefulness of external fiducial markers has been reported by several researchers [17-19].

After registration of the SPECT and CT images, a CT-derived attenuation coefficient map was created with the calibration curve for 201Tl using targeted nuclide software (HYOGO CM Attenuation Correction, Hyogo College of Medicine) [16]. The SPECT images were then reconstructed with and without attenuation correction by means of the ML-EM algorithm. In the final step, image fusion of both the reconstructed attenuation-corrected and non-attenuation-corrected SPECT and CT images was performed by reregistration of the external fiducial markers on a workstation (Fig. 1).


Figure 1
View larger version (18K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1 —Flow chart shows schema of SPECT and CT image processing. ML-EM = maximum-likelihood expectation maximization, AC = attenuation-corrected, NC = non-attenuation-corrected.

 
Quantitative Indexes
Lymph nodes with a short-axis diameter of more than 5 mm on CT images were selected for quantitative analysis. After registration of SPECT and CT images, ROIs were manually set on lymph nodes on the CT images. Using software, the mean counts of the ROIs for lymph nodes were then calculated on a computer workstation from the same ROI automatically set on corresponding sites of coregistered attenuation-corrected and non-attenuation-corrected SPECT images. The three quantitative indexes used for assessment were early ratio = EL / EB, delayed ratio = DL / DB, and washout ratio = (EL - DL) x 100 / EL, where EL is the count of the lymph node ROI on the early SPECT images, EB is the count of the background ROI on the early SPECT image, DL is the count of the lymph node ROI on the delayed SPECT image, and DB is the count of the background ROI on the delayed SPECT image. We selected fat tissue in the axilla for background because some patients have little fat tissue in the mediastinum. We also measured the short axis of the lymph nodes on the CT images.

Clinical-Pathologic Correlation in Lymph Nodes
A total of 181 lymph nodes measuring more than 5 mm in diameter were identified on the CT images of our 29 patients; 84 of these were diagnosed on the basis of histopathologic examination with H and E staining. The other 97 lymph nodes were diagnosed by clinical follow-up studies lasting more than 1 year. According to the American Joint Committee on Cancer (AJCC) and Union Internationale Contre le Cancer (UICC) [20] regional lymph node classification system, in 84 lymph nodes the site of surgical dissection matched that identified on CT images. In patients in whom metastatic lymph nodes were proven by surgery, the nodes were identified in the corresponding region on CT images based on their size and shape. Of the 84 histologically diagnosed lymph nodes, 15 were metastatic and 69 were not metastatic. Of 97 lymph nodes diagnosed on follow-up studies, those showing an obvious increase of 5 mm or more in short-axis diameter over time were defined as metastatic and subjected to sequential CT studies [21]. Lymph nodes that did not increase in size on follow-up CT performed over a period of 1 year were defined as nonmetastatic. Lymph nodes that did not fulfill either of these criteria (n = 25) were considered to be indeterminate and were excluded from assessment. Of these 97 lymph nodes, 51 were defined as metastatic and 21 as nonmetastatic. Of the 181 lymph nodes available at the inception of this study, 156 lymph nodes (66 with, 90 without metastasis) were selected for evaluation.

Quantitative Analysis
To compare the diagnostic value of our quantitative indexes, we used receiver operating characteristic (ROC) analysis that intraindividually evaluated the diagnostic performance of each index. Binormal ROC curves were generated with an ML-EM method. ROC analysis was performed using ROC-KIT (Windows 95 [Microsoft], version 0.9.1, BETA) developed by Charles E. Metz (University of Chicago). The Az and its SE (SE [Az]) were calculated as a measure of the likelihood of a correct test decision using a global decision variable [22].

Feasible threshold values for each index were set at a false-positive fraction of 0.05 (i.e., 95% specificity) to compare the diagnostic performance at low false-positive fractions. For each index, we calculated the sensitivity, specificity, positive and negative predictive values, and accuracy in the evaluation of lymph nodes (metastatic vs nonmetastatic) and in lymph node staging (N0-N1 vs N2-N3) [20]. The relevance of each quantitative index on SPECT images was compared with the relevance of the short-axis diameter on CT images using the McNemar test on statistical software (SPSS). A p value of less than 0.05 was considered to indicate a statistically significant difference.

Visual Analysis
Two experienced radiologists who had more than 10 years' experience in both nuclear medicine and CT evaluated conventional CT images and fused SPECT/CT images. The reviewers were unaware of the final pathology diagnoses, but they were informed of the clinical reasons for the scintigraphy and of the site of the suspected primary lesion. Reviewers initially interpreted CT images. Two weeks later, to avoid recall bias, fused images were evaluated by the same reviewers. Attenuation-corrected early phase SPECT images were used for fused images because this parameter showed the highest diagnostic performance (see Results, Quantitative Analysis).

For the interpretation of the CT images, the mediastinal lymph nodes with a diameter of less than 1 cm on the shortest axis were considered normal in size and those with a diameter of 1 cm or more were considered to be metastases [14, 23].

Fused images were classified as positive for lymph node metastases when there was one or more foci of well-defined increased 201Tl uptake in the mediastinum and hilum compared with background activity. Disagreements were resolved by consensus, with a third observer as a referee [14].

The diagnostic performance on fused images was compared with that on CT images using the McNemar test on statistical software (SPSS). A p value of less than 0.05 was considered to indicate a statistically significant difference.


Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Quantitative Analysis
ROC analysis showed that the Az values for early ratio (0.94 ± 0.02 on attenuation correction, 0.88 ± 0.03 on non-attenuation correction) and delayed ratio (0.87 ± 0.03 on attenuation correction, 0.81 ± 0.04 on non-attenuation correction) were superior to CT (0.78 ± 0.04) in the evaluation of lymph nodes for NSCLC staging. In addition, the Az for early ratio and delayed ratio on attenuation-corrected images was superior to the Az on images without attenuation correction. The Az for washout ratio (0.69 ± 0.04 on attenuation correction, 0.66 ± 0.04 on non-attenuation correction) was, however, inferior to the Az for CT. Quantitative indexes of early ratio and delayed ratio derived by SPECT were more useful than CT images. Attenuation correction increased the diagnostic accuracy. Early ratio on attenuation-corrected images was the most useful index for the differentiation between metastatic and nonmetastatic lymph nodes (Fig. 2).


Figure 2
View larger version (30K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2 —Receiver operating characteristic curves show areas under curve (Az) for diagnostic indexes. ER = early ratio, DR = delayed ratio, WR = washout ratio, NC = non-attenuation corrected, AC = attenuation corrected.

 
To assess the value of each index for the clinical staging of NSCLC, we set threshold values for each index at a false-positive fraction of 0.05. The threshold values were 1.59 for early ratio non-attenuation correction, 1.6 for early ratio attenuation correction, 1.36 for delayed ratio non-attenuation correction, 1.43 for delayed ratio attenuation correction, 48.3 for washout ratio non-attenuation correction, and 43 for washout ratio attenuation correction. The threshold value for the short-axis diameter of lymph nodes on CT images was 16 mm at the false-positive fraction of 0.05. Early ratio and delayed ratio on SPECT images were of higher diagnostic accuracy than the short-axis diameter on CT images, both for evaluating the metastatic and non-metastatic status of the lymph nodes and for their staging. In addition, attenuation correction improved diagnostic performance in the early ratio and delayed ratio; early ratio with attenuation correction yielded the highest performance. Our technique yielded results with a sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of 78.8%, 94.4%, 91.2%, 85.9%, and 87.8% in the evaluation of lymph nodes (metastatic vs nonmetastatic). These values were 84.6%, 100%, 100%, 88.9%, and 93.1% for lymph node staging (N0-N1 vs N2-N3), respectively (Tables 2 and 3).


View this table:
[in this window]
[in a new window]

 
TABLE 2: Quantitative Analysis of SPECT and CT for Evaluation of Lymph Node Metastases at False-Positive Fraction of 0.05 (Specificity, 95%)

 

View this table:
[in this window]
[in a new window]

 
TABLE 3: Quantitative Analysis of SPECT and CT for Staging Non–Small Cell Lung Cancer

 

Visual Analysis
The early images with attenuation correction showed higher performance than CT with a sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of 86.4%, 90.0%, 86.4%, 90.0%, and 88.5% in the evaluation of each lymph node metastasis. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were 84.6%, 93.8%, 91.7%, 88.2%, and 89.7% for lymph node staging (N0-N1 vs N2-N3), respectively (Tables 4 and 5).


View this table:
[in this window]
[in a new window]

 
TABLE 4: Visual Analysis of Imaging Performance for Lymph Node Metastases

 

View this table:
[in this window]
[in a new window]

 
TABLE 5: Visual Analysis of Imaging Performance for Staging

 


Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Although CT has been the primary method used for the diagnosis of lung cancer and the preoperative staging of NSCLC, its limited diagnostic accuracy renders it not highly useful for the evaluation of lymph node metastasis [4]. The sensitivity and specificity of CT were reported to be 46-79% and 44-94%, respectively [24-31]. Better results were obtained with 18F-FDG PET: Sensitivity and specificity were 76-93% and 81-100%, respectively [24-28]. Thallium-201 SPECT, 99mTc sestamibi, and 99mTc tetrofosmin have been also used to diagnose lymph node metastasis in NSCLC [10, 32, 33]. Yokoi et al. [10] showed that sensitivity and specificity were 76% and 92% for 201Tl SPECT and 62% and 80% for CT. Shiau et al. [32] reported that the sensitivity, specificity, and accuracy of sestamibi SPECT were 81.8%, 85.7%, and 84%, respectively; for chest CT, they were 36.3%, 85.7%, and 64%, respectively. Shiun et al. [33] also found that diagnostic accuracy was 85.3% with tetrofosmin SPECT and 73.5% with CT, and that 201Tl and other 99mTc agents were useful for the assessment of mediastinal involvement in NSCLC.

To our knowledge, the usefulness of quantitative indexes of 201Tl SPECT images for lymph node metastasis in NSCLC has not been reported. It is difficult to accurately identify small lesions such as lymph nodes because the spatial resolution of SPECT images is poor: The smallest lymph node detected by 201Tl SPECT was 1.5 cm [34]. Therefore, different or combined methods must be used for the quantitative evaluation of small lymph nodes. We used registered CT images for the placement of ROIs on SPECT images. When the ROIs were placed on the target lesions on CT images with the aid of software, they could be placed automatically on the corresponding sites on both the coregistered attenuation-corrected and the non-attenuation-corrected SPECT images. Because it is relatively easy to set ROIs for lymph nodes, unless severe misregistration occurs between SPECT and CT images the quantitative evaluation of lymph nodes is possible. On fused images, we could easily distinguish between lymph node accumulations and physiologic accumulations of 201Tl (Figs. 3A, 3B, and 3C).


Figure 3
View larger version (25K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3A —51-year-old woman with adenocarcinoma of right middle lobe of lung (arrowheads). CT images depict subcarinal (large arrow) and mediastinal (small arrow) lymph nodes.

 

Figure 4
View larger version (31K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3B —51-year-old woman with adenocarcinoma of right middle lobe of lung (arrowheads). Although attenuation-corrected SPECT images (early phase) reveal multiple high accumulations (arrows), anatomic information is poor.

 

Figure 5
View larger version (32K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3C —51-year-old woman with adenocarcinoma of right middle lobe of lung (arrowheads). On fused SPECT/CT images, accumulations of right hilar and mediastinal lymph nodes (open arrows) may be distinguished from heart and vertebra (dotted arrows). All lymph nodes with thallium-201 accumulation were confirmed at surgical pathology to be metastatic.

 
Accurate registration is also important for the attenuation correction of SPECT images and the evaluation of lymph nodes. Our combined SPECT/CT system, which allows SPECT and high-quality MDCT to be performed on a common table, avoided positional displacement of patients between SPECT and CT. Therefore, we were able to register 201Tl SPECT and CT images accurately and to perform attenuation correction of the SPECT images. Even with the combined imaging systems, registration errors between SPECT and CT images may occur because the subjects breathe during the procedure. To reduce the effect of breathing on registration, we used two breathing methods during CT. First, CT images for attenuation correction were obtained with patients breathing freely to mimic the situation during SPECT image acquisition. Second, for lymph node evaluation, the patients were in breath-holding exhalation position because we found that CT images acquired under this condition best matched the corresponding SPECT images obtained under various breath-holding conditions.

The retention index is useful for evaluating primary lung cancer. Arbab et al. [35] showed that the retention index on 201Tl SPECT was particularly useful for differentiating malignant and benign lung lesions, and Takekawa et al. [36] found it useful for the prediction of prognoses. Mathematically, the retention index is expressed as a negative value of washout ratio (retention index = -washout ratio). In previous evaluations of primary lung lesions, ROIs for background were usually set on the lung fields, and the washout of tracer was evaluated relative to the lung. On the other hand, we chose fat tissue as the background for quantitative indexes because lymph nodes are located in fat tissue of the mediastinum. Therefore, we used washout ratio as a diagnostic index instead of retention index.

In our study, the Az value showed that for diagnosing lymph nodes, the performance of early ratio was superior to that of delayed ratio, washout ratio, or CT (Fig. 2). Moreover, for both the evaluation of lymph nodes for metastasis and for lymph node staging, the early ratio on SPECT images yielded the highest diagnostic accuracy in individual patients. This suggests that tracer accumulation in the metastatic lymph nodes is stronger in the early than in the delayed phase, resulting in the superior performance of the early ratio. Diagnostic accuracy at all quantitative indexes was higher on attenuation-corrected SPECT than on non-attenuation-corrected SPECT images (Figs. 2, 4A, 4B, 4C, and 4D, Table 3). Attenuation correction may improve diagnostic accuracy when quantitative indexes derived from SPECT images are used for clinical evaluations. Visual analysis also showed early fused images were useful for differentiating metastatic from nonmetastatic lymph nodes, which led to better performance in staging.


Figure 6
View larger version (63K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4A —63-year-old man with large cell carcinoma of left lower lobe. Transverse SPECT images show accumulation of thallium-201 in a mediastinal lymph node (arrowheads). On early images without (A) and with (B) attenuation correction, accumulation of thallium-201 in lymph nodes was higher than on delayed images without (C) and with (D) attenuation correction. On early (B) and delayed (D) images with attenuation correction, accumulation in lymph nodes was more clearly depicted than on early (A) and delayed (C) images without attenuation correction.

 

Figure 7
View larger version (69K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4B —63-year-old man with large cell carcinoma of left lower lobe. Transverse SPECT images show accumulation of thallium-201 in a mediastinal lymph node (arrowheads). On early images without (A) and with (B) attenuation correction, accumulation of thallium-201 in lymph nodes was higher than on delayed images without (C) and with (D) attenuation correction. On early (B) and delayed (D) images with attenuation correction, accumulation in lymph nodes was more clearly depicted than on early (A) and delayed (C) images without attenuation correction.

 

Figure 8
View larger version (62K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4C —63-year-old man with large cell carcinoma of left lower lobe. Transverse SPECT images show accumulation of thallium-201 in a mediastinal lymph node (arrowheads). On early images without (A) and with (B) attenuation correction, accumulation of thallium-201 in lymph nodes was higher than on delayed images without (C) and with (D) attenuation correction. On early (B) and delayed (D) images with attenuation correction, accumulation in lymph nodes was more clearly depicted than on early (A) and delayed (C) images without attenuation correction.

 

Figure 9
View larger version (70K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4D —63-year-old man with large cell carcinoma of left lower lobe. Transverse SPECT images show accumulation of thallium-201 in a mediastinal lymph node (arrowheads). On early images without (A) and with (B) attenuation correction, accumulation of thallium-201 in lymph nodes was higher than on delayed images without (C) and with (D) attenuation correction. On early (B) and delayed (D) images with attenuation correction, accumulation in lymph nodes was more clearly depicted than on early (A) and delayed (C) images without attenuation correction.

 

Although we performed image fusion manually, we confirmed the validity of our image fusion by registering external fiducial markers attached to the platform. This is a time-consuming procedure that might limit the routine use of this technique. Improved software algorithms are needed for automatic and robust image fusion. Considerable progress has been made in the development of fusion software to coregister different imaging techniques [37, 38]. Slomka et al. [38] developed a technique for automatic nonlinear registration of CT and PET whole-body images to common spatial coordinates. This technique may be applied in the automatic fusion of SPECT with CT acquired on stand-alone scanners during normal breathing or breath-holding data acquisition.

Our study has several limitations. First, quantitative assessment was performed only in patients with 201Tl accumulation in the primary lesion, and the study of additional patients with NSCLC may yield different results. Second, our study population included a small number of patients with nodal stages N1 and N2. Third, at present our combined SPECT/CT system is not widely used because it involves increased costs and is not commercially available. Image fusion of SPECT and CT frequently must be performed during separate imaging sessions using separate scanners, a situation dictated by clinical requirements or available facilities.

In conclusion, using a combined SPECT/CT system, we showed that fusion images that combine CT-based anatomic information with SPECT-based functional images are useful for quantitative analysis. ROC multiindex analysis of fused SPECT/CT images indicated that the early ratio on 201Tl SPECT images had the highest diagnostic accuracy. We also found that attenuation correction was effective for detecting lymph node metastasis in patients with NSCLC.


References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 

  1. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54 : 8-29[Abstract/Free Full Text]
  2. Weinmann M, Jeremic B, Toomes H, Friedel G, Bamberg M. Treatment of lung cancer in the elderly. I. Non-small cell lung cancer. Lung Cancer 2003; 39:233 -253[CrossRef][Medline]
  3. Mountain CF. The international system for staging lung cancer. Semin Surg Oncol 2000;18 : 106-115[CrossRef][Medline]
  4. Prenzel KL, Monig SP, Sinning JM, et al. Lymph node size and metastatic infiltration in non-small cell lung cancer. Chest 2003; 123:463 -467[Abstract/Free Full Text]
  5. Lloyd C, Silvestri GA. Mediastinal staging of non-small cell lung cancer. Cancer Control 2001;8 : 311-317[Medline]
  6. Farrell MA, McAdams HP, Herndon JE, Patz EF Jr. Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease. Radiology 2000;215 : 886-890[Abstract/Free Full Text]
  7. van Tinteren H, Hoekstra OS, Smit EF, et al. Effectiveness of PET in the preoperative assessment of patients with suspected non-small cell lung cancer: the PLUS multicenter randomized trial. Lancet2002; 359:1388 -1393[CrossRef][Medline]
  8. Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000;41 : 1369-1379[Abstract/Free Full Text]
  9. Antoch G, Stattaus J, Nemat AT, et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 2003;229 : 526-533[Abstract/Free Full Text]
  10. Yokoi K, Okuyama A, Mori K, et al. Mediastinal lymph node metastasis from lung cancer: evaluation with 201Tl SPECT—comparison with CT. Radiology1994; 192:813 -817[Abstract/Free Full Text]
  11. Yamamoto Y, Nishiyama Y, Satoh K, et al. Comparative evaluation of 99mTc MIBI and 201Tl chloride SPECT in non-small cell lung cancer mediastinal lymph node metastases. Clin Nucl Med 2000; 25:29 -32[Medline]
  12. Chiti A, Maffioli LS, Infante M, et al. Assessment of mediastinal involvement in lung cancer with 99mTc-sestamibi SPECT. J Nucl Med 1996; 37:938 -942[Abstract/Free Full Text]
  13. Nosotti M, Santambrogio L, Gasparini M, Baisi A, Bellaviti N, Rosso L. Role of (99m)Tc-hexakis-2-methoxy-isobutylisonitrile in the diagnosis and staging of lung cancer. Chest 2002;122 : 1361-1364[Abstract/Free Full Text]
  14. Schillaci O, Spanu A, Scopinaro F, et al. Mediastinal lymph node involvement in non-small cell lung cancer: evaluation with 99mTc-tetrofosmin SPECT and comparison with CT. J Nucl Med 2003; 44:1219 -1224[Abstract/Free Full Text]
  15. Schillaci O, Danieli R, Manni C, Simonetti G. Is SPECT/CT with a hybrid camera useful to improve scintigraphic imaging interpretation? Nucl Med Commun 2004;25 : 705-710[CrossRef][Medline]
  16. Kashiwagi T, Yutani K, Fukuchi M, et al. Correction of nonuniform attenuation and image fusion in SPECT by means of separate X-ray CT. Ann Nucl Med 2002;16 : 255-261[Medline]
  17. Hutton BF, Braun M. Software for image registration: algorithms, accuracy, efficacy. Semin Nucl Med 2003;33 : 180-192[CrossRef][Medline]
  18. Papavasileiou P, Flux GD, Flower MA, Guy MJ. An automated technique for SPECT marker-based image registration in radionuclide therapy. Phys Med Biol 2001;46 : 2085-2097[Medline]
  19. Barnden L, Kwiatek R, Lau Y, et al. Validation of fully automatic brain SPECT to MR coregistration. Eur J Nucl Med2000; 27:147 -154[Medline]
  20. Cymbalista M, Waysberg A, Zacharias C, et al. CT demonstration of the 1996 AJCC-UICC regional lymph node classification for lung cancer staging. RadioGraphics 1999;19 : 899-900 poster[Abstract/Free Full Text]
  21. Marom EM, McAdams HP, Erasmus JJ, et al. Staging non-small cell lung cancer with whole-body PET. Radiology1999; 212:803 -809[Abstract/Free Full Text]
  22. Metz CE, Herman BA, Shen JH. Maximum likelihood estimation of receiver operating characteristic (ROC) curves from continuously distributed data. Stat Med 1998;17 : 1033-1053[CrossRef][Medline]
  23. Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s—meta-analytic comparison of PET and CT. Radiology 1999;213 : 530-536[Abstract/Free Full Text]
  24. Steinert HC, Hauser M, Allemann F, et al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 1997;202 : 441-446[Abstract/Free Full Text]
  25. Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology1994; 191:371 -377[Abstract/Free Full Text]
  26. Sasaki M, Ichiya Y, Kuwabara Y, et al. The usefulness of FDG PET for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray CT. Eur J Nucl Med 1996; 23:741 -747[CrossRef][Medline]
  27. Guhlmann A, Storck M, Kotzerke J, Moog F, Sunder-Plassmann L, Reske SN. Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG PET. Thorax 1997;52 : 438-441[Abstract]
  28. Vansteenkiste JF, Stroobants SG, De Leyn PR, et al. Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Leuven Lung Cancer Group. Chest 1997;112 : 1480-1486[Abstract/Free Full Text]
  29. McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology1992; 182:319 -323[Abstract/Free Full Text]
  30. Staples CA, Muller NL, Miller RR, Evans KG, Nelems B. Mediastinal nodes in bronchogenic carcinoma: comparison between CT and mediastinoscopy. Radiology 1988;167 : 367-372[Abstract/Free Full Text]
  31. Webb WR, Gatsonis C, Zerhouni EA, et al. CT and MRI in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991;178 : 705-713[Abstract/Free Full Text]
  32. Shiau YC, Hsieh JF, Tsai SC, Ho YJ, Sun SS, Kao CH. 99mTc methoxy-isobutyl-isonitrile chest SPECT to detect mediastinal lymph node metastasis in patients with non-small cell lung cancer: comparison with CT. Anticancer Res 2000;20 : 3751-3754[Medline]
  33. Shiun SC, Sun SS, Hsu NY, Kao CH, Lin CC, Lee CC. Detecting mediastinal lymph node metastases in non-small cell lung cancer using a combination of 99mTc tetrofosmin chest SPECT and chest CT. Cancer Invest 2002;20 : 311-317[CrossRef][Medline]
  34. Tonami N, Shuke N, Yokoyama K, et al. 201Tl SPECT in the evaluation of suspected lung cancer. J Nucl Med1989; 30:997 -1004[Abstract/Free Full Text]
  35. Arbab AS, Koizumi K, Toyama K, Arai T, Yoshitomi T, Araki T. Detection of lung lesions and lymph nodes with 201Tl SPET. Nucl Med Commun 1998;19 : 411-416[Medline]
  36. Takekawa H, Itoh K, Abe S, et al. Retention index of 201Tl single photon emission computerised tomography (SPECT) as an indicator of metastasis in adenocarcinoma of the lung. Br J Cancer 1994; 70:315 -318[Medline]
  37. Townsend DW, Cherry SR. Combining anatomy and function: the path to true image fusion. Eur Radiol 2001;11 : 1968-1974[CrossRef][Medline]
  38. Slomka PJ, Dey D, Przetak C, Aladl UE, Baum RP. Automated 3D registration of stand-alone (18)F-FDG whole-body PET with CT. J Nucl Med 2003; 44:1156 -1167[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shiraishi, S.
Right arrow Articles by Yamashita, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shiraishi, S.
Right arrow Articles by Yamashita, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS